ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA notes Paratek antibiotic’s noninferiority as it heads to AdComm vote
August 08, 2018Paratek Pharmaceuticals’ first drug, and the first in a new class of broad-spectrum antibiotics called aminomethylcyclines, has shown to be noninferior to current regimens for bacterial pneumonia and skin infections, FDA reviewers wrote ahead of an Aug. 8
Pharma Sources Insight January 2025
